Browse studies

Find your next paid study

27,235 recruiting studies available now

An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM0…

Pulmonary Fibrosis

Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT07441408

Phase 2

A Multicenter, Open-Label, Single-Group Clinical Study to Assess the Pharmacokinetics, Safety and Efficacy of Nemolizumab in Pediatric Subjects (Aged 6 to 23 Months) With Moderate-to-Severe Atopic Dermatitis Not Adequately Controlled With Topical Therapy

The primary objective of the study is to assess the pharmacokinetics (PK) and safety of nemolizumab in pediatric participants (aged 6-23 months) with moderate-…

Moderate-to-Severe Atopic Dermatitis

Estimated

~$10 – $7,500

Galderma R&DNCT07660835

Phase 1

Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

This is a Phase I/II, multi-site, open-label, single arm study to describe the pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB) initiated…

Hepatitis C

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07040319

Title: A Single-arm, Open-label, Prospective, Multicenter Safety Study to Evaluate the Occurrence of Essential Fatty Acid Deficiency (EFAD) in Pediatric Patients With Parenteral Nutrition-associated Cholestasis (PNAC) Who Require More Than Eight Weeks of Omegaven Treatment

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a sourc…

Parenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more

Estimated

~$10 – $1,125

Fresenius KabiNCT06274788

Observational

Implementation of a Navigation Program for Breast Cancer Survivors

This clinical trial studies whether a navigation program improves survivorship support service participation among survivors of breast cancer that has not spre…

Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT07699991

Observational

An Open Label, Single Center Study to Evaluate the Effect of Protein Loading on the Measurement of Renal Reserve Using the MediBeacon® Transdermal GFR System

The goal of this clinical trial is to evaluate the effect of protein loading on the measurement of renal reserve using the MediBeacon Transdermal glomerular fi…

Glomerular Filtration Rate

Estimated

~$10 – $7,500

MediBeaconNCT07335614

Observational

Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries

The prevalence of autonomic dysfunction and sleep disordered breathing (SDB) is increased in individuals with spinal cord injury (SCI). The loss of autonomic c…

Spinal Cord InjuriesAutonomic Dysreflexia

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT05351827

Phase 1

An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-2828 in Participants With Renal Impairment

The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to le…

Chronic Kidney FailureEnd-Stage Renal DiseaseRenal Impairment

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07348237

Observational

COVID-19: A Virtual Feasibility Study to Manage Stress

This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated …

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04776941

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Background: Neurofibromatosis 1 (NF1) is a disease that causes tumors to grow along the nerves. These include plexiform neurofibromas (pNF) and cutaneous neur…

Neurofibromatosis Type 1Neurofibroma

Estimated

~$10 – $675

National Cancer Institute (NCI)NCT06880991

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at …

Neoplasm, ColorectalCognitive ImpairmentCognitive Dysfunction+5 more

Estimated

~$10 – $1,125

Joseph McCollomNCT05014399

Observational

Cortical Excitability in Cyclic Vomiting Syndrome

This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and heal…

Cyclic Vomiting Syndrome

Estimated

~$10 – $6,250

University of PittsburghNCT05256160